(S (PP (IN Amid) (NP (DT the) (JJ ongoing) (NNP COVID-19) (NN pandemic))) (, ,) (SBAR (IN whether) (S (NP (NP (JJ COVID-19) (NNS patients)) (PP (IN with) (NP (JJ high) (NNS risks)))) (VP (MD can) (VP (VB be) (VP (VP (VBN recovered)) (CC or) (RB not)))))) (VP (NNS depends) (, ,) (PP (TO to) (NP (DT a) (JJ large) (NN extent))) (, ,) (PP (IN on) (SBAR (WHADVP (WRB how) (JJ early)) (S (NP (PRP they)) (VP (MD will) (VP (VB be) (VP (VBN treated) (ADVP (RB appropriately)) (SBAR (IN before) (S (NP (JJ irreversible) (NNS consequences)) (VP (VBP are) (VP (VBN caused) (PP (TO to) (NP (DT the) (NNS patients))) (PP (IN by) (NP (DT the) (NN virus)))))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN research))) (, ,) (NP (PRP we)) (VP (VBD reported) (NP (NP (DT an) (ADJP (JJ explainable) (, ,) (JJ intuitive) (, ,) (CC and) (JJ accurate)) (NN machine) (VBG learning) (NNS model)) (VP (VBN based) (PP (IN on) (NP (JJ logistic) (NN regression))) (S (VP (TO to) (VP (VB predict) (NP (NP (DT the) (NN fatality) (NN rate)) (PP (IN of) (NP (NNP COVID-19) (NNS patients)))) (S (VP (VBG using) (NP (NP (QP (RB only) (CD three)) (JJ important) (NN blood) (NNS biomarkers)) (, ,) (PP (VBG including) (NP (NP (NP (JJ lactic) (NN dehydrogenase)) (, ,) (NP (NP (FW lymphocyte)) (PRN (-LRB- -LRB-) (NP (NN %)) (-RRB- -RRB-))) (CC and) (NP (JJ high-sensitivity) (JJ C-reactive) (NN protein))) (, ,) (CC and) (NP (PRP$ their) (NNS interactions))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (SBAR (WHADVP (WRB when)) (S (NP (NP (DT the) (NN fatality) (NN probability)) (VP (VBN produced) (PP (IN by) (NP (DT the) (JJ logistic) (NN regression) (NN model))))) (VP (VBD was) (PP (IN over) (NP (CD 0.8)))))) (, ,) (NP (DT the) (NN model)) (VP (VBD had) (NP (DT the) (JJ optimal) (NN performance)) (SBAR (IN in) (DT that) (S (NP (PRP it)) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VB predict) (NP (JJ patient) (NNS fatalities)) (ADVP (NP (QP (RBR more) (IN than) (CD 11.30)) (NNS days)) (PP (IN on) (NP (NN average)))) (PP (IN with) (NP (NP (NP (RB maximally) (CD 34.91) (NNS days)) (PP (IN in) (NP (NN advance)))) (, ,) (NP (NP (DT an) (JJ accumulative) (NN f1-score)) (PP (IN of) (NP (CD 93.76) (NN %)))) (CC and) (CC and) (NP (NP (DT an) (JJ accumulative) (NN accuracy) (NN score)) (PP (IN of) (NP (CD 93.92) (NN %))))))))))))))))) (. .))
(S (NP (JJ Such) (DT a) (NN model)) (VP (MD can) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VP (VB identify) (NP (NP (JJ COVID-19) (NNS patients)) (PP (IN with) (NP (JJ high) (NNS risks))) (PP (IN with) (NP (CD three) (NN blood) (NNS biomarkers))))) (CC and) (VP (VB help) (S (NP (NP (DT the) (JJ medical) (NNS systems)) (PP (IN around) (NP (DT the) (NN world)))) (VP (NN plan) (NP (JJ critical) (JJ medical) (NNS resources)) (PP (IN amid) (NP (DT this) (NN pandemic)))))))))))) (. .))
